 | • レポートコード：QY20ST-06944 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥580,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥870,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,160,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界のグリキドン市場について種類別（グリキノン錠、グリキノン徐放錠、グレキノンカプセル、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・グリキドン市場の概要 ・世界の主要地域別グリキドン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のグリキドン市場規模2015-2026：種類別（グリキノン錠、グリキノン徐放錠、グレキノンカプセル、その他） ・世界のグリキドン市場規模2015-2026：用途別（病院薬局、小売薬局、オンライン薬局） ・グリキドンの北米市場規模2015-2020 ・グリキドンのヨーロッパ市場規模2015-2020 ・グリキドンの中国市場規模2015-2020 ・グリキドンの日本市場規模2015-2020 ・グリキドンの東南アジア市場規模2015-2020 ・グリキドンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・グリキドンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・グリキドンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Gliquidone (CAS 33342-05-1) Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Gliquidone (CAS 33342-05-1) market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Gliquidone (CAS 33342-05-1), C27H33N3O6S, the formula weight is 527.63, and its form is white powder.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Gliquidone (CAS 33342-05-1) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Gliquidone (CAS 33342-05-1) industry.
Based on our recent survey, we have several different scenarios about the Gliquidone (CAS 33342-05-1) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Gliquidone (CAS 33342-05-1) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Gliquidone (CAS 33342-05-1) market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Gliquidone (CAS 33342-05-1) market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Gliquidone (CAS 33342-05-1) market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Gliquidone (CAS 33342-05-1) market. The report also includes nautical information, where it shows Gliquidone (CAS 33342-05-1) market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Gliquidone (CAS 33342-05-1) market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Gliquidone (CAS 33342-05-1) market.
Glycollinone is a second-generation oral sulfonylurea hypoglycemic agent. It is a highly active pro-islet β-cell agent that binds to specific receptors on the islet β-cell membrane and induces the production of appropriate amounts of insulin to lower blood glucose levels.
Geographical Analysis:
Based on region, the global Gliquidone (CAS 33342-05-1) market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Gliquidone (CAS 33342-05-1) market are
Vanguard Pharma
Yiling Pharma
CR Double-Crane
TIPR
Jinheng Pharma
Dexa Medica
Boehringer Ingelheim
Menarini Belgium
Segment by Type
Glequinone Tablets
Glequinone Sustained Release Tablets
Glequinone Capsule
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Gliquidone (CAS 33342-05-1) market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Gliquidone (CAS 33342-05-1) market.
• The market share of the global Gliquidone (CAS 33342-05-1) market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Gliquidone (CAS 33342-05-1) market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Gliquidone (CAS 33342-05-1) market.
1 Gliquidone (CAS 33342-05-1) Market Overview
1.1 Gliquidone (CAS 33342-05-1) Product Scope
1.2 Gliquidone (CAS 33342-05-1) Segment by Type
1.2.1 Global Gliquidone (CAS 33342-05-1) Sales by Type (2020-2026)
1.2.2 Glequinone Tablets
1.2.3 Glequinone Sustained Release Tablets
1.2.4 Glequinone Capsule
1.2.5 Others
1.3 Gliquidone (CAS 33342-05-1) Segment by Application
1.3.1 Global Gliquidone (CAS 33342-05-1) Sales Comparison by Application (2020-2026)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Gliquidone (CAS 33342-05-1) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Gliquidone (CAS 33342-05-1) Sales Growth Rate (2015-2026)
1.4.2 Global Gliquidone (CAS 33342-05-1) Revenue and Growth Rate (2015-2026)
1.4.3 Global Gliquidone (CAS 33342-05-1) Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Gliquidone (CAS 33342-05-1) Industry Impact
1.5.1 How the Covid-19 is Affecting the Gliquidone (CAS 33342-05-1) Industry
1.5.1.1 Gliquidone (CAS 33342-05-1) Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Gliquidone (CAS 33342-05-1) Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Gliquidone (CAS 33342-05-1) Players to Combat Covid-19 Impact
2 Gliquidone (CAS 33342-05-1) Estimate and Forecast by Region
2.1 Global Gliquidone (CAS 33342-05-1) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Gliquidone (CAS 33342-05-1) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Gliquidone (CAS 33342-05-1) Sales Market Share by Region (2015-2020)
2.2.2 Global Gliquidone (CAS 33342-05-1) Revenue Market Share by Region (2015-2020)
2.3 Global Gliquidone (CAS 33342-05-1) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Gliquidone (CAS 33342-05-1) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Gliquidone (CAS 33342-05-1) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Gliquidone (CAS 33342-05-1) Estimates and Projections (2015-2026)
2.4.2 Europe Gliquidone (CAS 33342-05-1) Estimates and Projections (2015-2026)
2.4.3 China Gliquidone (CAS 33342-05-1) Estimates and Projections (2015-2026)
2.4.4 Japan Gliquidone (CAS 33342-05-1) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Gliquidone (CAS 33342-05-1) Estimates and Projections (2015-2026)
2.4.6 India Gliquidone (CAS 33342-05-1) Estimates and Projections (2015-2026)
3 Global Gliquidone (CAS 33342-05-1) Competition Landscape by Players
3.1 Global Top Gliquidone (CAS 33342-05-1) Players by Sales (2015-2020)
3.2 Global Top Gliquidone (CAS 33342-05-1) Players by Revenue (2015-2020)
3.3 Global Gliquidone (CAS 33342-05-1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gliquidone (CAS 33342-05-1) as of 2019)
3.4 Global Gliquidone (CAS 33342-05-1) Average Price by Company (2015-2020)
3.5 Manufacturers Gliquidone (CAS 33342-05-1) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Gliquidone (CAS 33342-05-1) Players (Opinion Leaders)
4 Global Gliquidone (CAS 33342-05-1) Market Size by Type
4.1 Global Gliquidone (CAS 33342-05-1) Historic Market Review by Type (2015-2020)
4.1.1 Global Gliquidone (CAS 33342-05-1) Sales Market Share by Type (2015-2020)
4.1.2 Global Gliquidone (CAS 33342-05-1) Revenue Market Share by Type (2015-2020)
4.1.3 Global Gliquidone (CAS 33342-05-1) Price by Type (2014-2020)
4.2 Global Gliquidone (CAS 33342-05-1) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Gliquidone (CAS 33342-05-1) Sales Forecast by Type (2021-2026)
4.2.2 Global Gliquidone (CAS 33342-05-1) Revenue Forecast by Type (2021-2026)
4.2.3 Global Gliquidone (CAS 33342-05-1) Price Forecast by Type (2021-2026)
5 Global Gliquidone (CAS 33342-05-1) Market Size by Application
5.1 Global Gliquidone (CAS 33342-05-1) Historic Market Review by Application (2015-2020)
5.1.1 Global Gliquidone (CAS 33342-05-1) Sales Market Share by Application (2015-2020)
5.1.2 Global Gliquidone (CAS 33342-05-1) Revenue Market Share by Application (2015-2020)
5.1.3 Global Gliquidone (CAS 33342-05-1) Price by Application (2015-2020)
5.2 Global Gliquidone (CAS 33342-05-1) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Gliquidone (CAS 33342-05-1) Sales Forecast by Application (2021-2026)
5.2.2 Global Gliquidone (CAS 33342-05-1) Revenue Forecast by Application (2021-2026)
5.2.3 Global Gliquidone (CAS 33342-05-1) Price Forecast by Application (2021-2026)
3 North America Gliquidone (CAS 33342-05-1) Market Facts & Figures
3.2 North America Gliquidone (CAS 33342-05-1) Sales Market Share by Company (2015-2020)
3.3 North America Gliquidone (CAS 33342-05-1) Sales Market Share by Type (2015-2020)
3.4 North America Gliquidone (CAS 33342-05-1) Sales Market Share by Application (2015-2020)
4 Europe Gliquidone (CAS 33342-05-1) Market Facts & Figures
4.2 Europe Gliquidone (CAS 33342-05-1) Sales Market Share by Company (2015-2020)
4.3 Europe Gliquidone (CAS 33342-05-1) Sales Market Share by Type (2015-2020)
4.4 Europe Gliquidone (CAS 33342-05-1) Sales Market Share by Application (2015-2020)
5 China Gliquidone (CAS 33342-05-1) Market Facts & Figures
5.2 China Gliquidone (CAS 33342-05-1) Sales Market Share by Company (2015-2020)
5.3 China Gliquidone (CAS 33342-05-1) Sales Market Share by Type (2015-2020)
5.4 China Gliquidone (CAS 33342-05-1) Sales Market Share by Application (2015-2020)
6 Japan Gliquidone (CAS 33342-05-1) Market Facts & Figures
6.2 Japan Gliquidone (CAS 33342-05-1) Sales Market Share by Company (2015-2020)
6.3 Japan Gliquidone (CAS 33342-05-1) Sales Market Share by Type (2015-2020)
6.4 Japan Gliquidone (CAS 33342-05-1) Sales Market Share by Application (2015-2020)
7 Southeast Asia Gliquidone (CAS 33342-05-1) Market Facts & Figures
7.2 Southeast Asia Gliquidone (CAS 33342-05-1) Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Gliquidone (CAS 33342-05-1) Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Gliquidone (CAS 33342-05-1) Sales Market Share by Application (2015-2020)
8 India Gliquidone (CAS 33342-05-1) Market Facts & Figures
8.2 India Gliquidone (CAS 33342-05-1) Sales Market Share by Company (2015-2020)
8.3 India Gliquidone (CAS 33342-05-1) Sales Market Share by Type (2015-2020)
8.4 India Gliquidone (CAS 33342-05-1) Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Gliquidone (CAS 33342-05-1) Business
12.1 Vanguard Pharma
12.1.1 Vanguard Pharma Gliquidone (CAS 33342-05-1) Corporation Information
12.1.2 Vanguard Pharma Gliquidone (CAS 33342-05-1) Business Overview and Total Revenue
12.1.3 Vanguard Pharma Gliquidone (CAS 33342-05-1) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Vanguard Pharma Gliquidone (CAS 33342-05-1) Products Offered
12.1.5 Vanguard Pharma Recent Development
12.2 Yiling Pharma
12.2.1 Yiling Pharma Gliquidone (CAS 33342-05-1) Corporation Information
12.2.2 Yiling Pharma Gliquidone (CAS 33342-05-1) Business Overview and Total Revenue
12.2.3 Yiling Pharma Gliquidone (CAS 33342-05-1) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Yiling Pharma Gliquidone (CAS 33342-05-1) Products Offered
12.2.5 Yiling Pharma Recent Development
12.3 CR Double-Crane
12.3.1 CR Double-Crane Gliquidone (CAS 33342-05-1) Corporation Information
12.3.2 CR Double-Crane Gliquidone (CAS 33342-05-1) Business Overview and Total Revenue
12.3.3 CR Double-Crane Gliquidone (CAS 33342-05-1) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 CR Double-Crane Gliquidone (CAS 33342-05-1) Products Offered
12.3.5 CR Double-Crane Recent Development
12.4 TIPR
12.4.1 TIPR Gliquidone (CAS 33342-05-1) Corporation Information
12.4.2 TIPR Gliquidone (CAS 33342-05-1) Business Overview and Total Revenue
12.4.3 TIPR Gliquidone (CAS 33342-05-1) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 TIPR Gliquidone (CAS 33342-05-1) Products Offered
12.4.5 TIPR Recent Development
12.5 Jinheng Pharma
12.5.1 Jinheng Pharma Gliquidone (CAS 33342-05-1) Corporation Information
12.5.2 Jinheng Pharma Gliquidone (CAS 33342-05-1) Business Overview and Total Revenue
12.5.3 Jinheng Pharma Gliquidone (CAS 33342-05-1) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Jinheng Pharma Gliquidone (CAS 33342-05-1) Products Offered
12.5.5 Jinheng Pharma Recent Development
12.6 Dexa Medica
12.6.1 Dexa Medica Gliquidone (CAS 33342-05-1) Corporation Information
12.6.2 Dexa Medica Gliquidone (CAS 33342-05-1) Business Overview and Total Revenue
12.6.3 Dexa Medica Gliquidone (CAS 33342-05-1) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Dexa Medica Gliquidone (CAS 33342-05-1) Products Offered
12.6.5 Dexa Medica Recent Development
12.7 Boehringer Ingelheim
12.7.1 Boehringer Ingelheim Gliquidone (CAS 33342-05-1) Corporation Information
12.7.2 Boehringer Ingelheim Gliquidone (CAS 33342-05-1) Business Overview and Total Revenue
12.7.3 Boehringer Ingelheim Gliquidone (CAS 33342-05-1) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Boehringer Ingelheim Gliquidone (CAS 33342-05-1) Products Offered
12.7.5 Boehringer Ingelheim Recent Development
12.8 Menarini Belgium
12.8.1 Menarini Belgium Gliquidone (CAS 33342-05-1) Corporation Information
12.8.2 Menarini Belgium Gliquidone (CAS 33342-05-1) Business Overview and Total Revenue
12.8.3 Menarini Belgium Gliquidone (CAS 33342-05-1) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Menarini Belgium Gliquidone (CAS 33342-05-1) Products Offered
12.8.5 Menarini Belgium Recent Development
13 Gliquidone (CAS 33342-05-1) Manufacturing Cost Analysis
13.1 Gliquidone (CAS 33342-05-1) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Gliquidone (CAS 33342-05-1)
13.4 Gliquidone (CAS 33342-05-1) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Gliquidone (CAS 33342-05-1) Distributors List
14.3 Gliquidone (CAS 33342-05-1) Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Gliquidone (CAS 33342-05-1) Sales (Kg) Growth Rate by Type (2020-2026)
Table 2. Global Gliquidone (CAS 33342-05-1) Sales (Kg) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Gliquidone (CAS 33342-05-1) Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Gliquidone (CAS 33342-05-1) Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Gliquidone (CAS 33342-05-1) Players to Combat Covid-19 Impact
Table 8. Global Market Gliquidone (CAS 33342-05-1) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Gliquidone (CAS 33342-05-1) Sales (Kg) by Region (2015-2020)
Table 10. Global Gliquidone (CAS 33342-05-1) Sales Market Share by Region (2015-2020)
Table 11. Global Gliquidone (CAS 33342-05-1) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Gliquidone (CAS 33342-05-1) Revenue Share by Region (2015-2020)
Table 13. Global Gliquidone (CAS 33342-05-1) Sales (Kg) Forecast by Region (2021-2026)
Table 14. Global Gliquidone (CAS 33342-05-1) Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Gliquidone (CAS 33342-05-1) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Gliquidone (CAS 33342-05-1) Revenue Share Forecast by Region (2021-2026)
Table 17. Global Gliquidone (CAS 33342-05-1) (Kg) of Key Companies (2015-2020)
Table 18. Global Gliquidone (CAS 33342-05-1) Sales Share by Company (2015-2020)
Table 19. Global Gliquidone (CAS 33342-05-1) Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Gliquidone (CAS 33342-05-1) Revenue Share by Company (2015-2020)
Table 21. Global Gliquidone (CAS 33342-05-1) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gliquidone (CAS 33342-05-1) as of 2019)
Table 22. Global Gliquidone (CAS 33342-05-1) Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Gliquidone (CAS 33342-05-1) Manufacturing Sites and Area Served
Table 24. Manufacturers Gliquidone (CAS 33342-05-1) Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Gliquidone (CAS 33342-05-1) Players
Table 27. Global Gliquidone (CAS 33342-05-1) Sales (Kg) by Type (2015-2020)
Table 28. Global Gliquidone (CAS 33342-05-1) Sales Share by Type (2015-2020)
Table 29. Global Gliquidone (CAS 33342-05-1) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Gliquidone (CAS 33342-05-1) Price (Kg) by Type (2015-2020)
Table 31. Global Gliquidone (CAS 33342-05-1) Sales Share by Type (2021-2026)
Table 32. Global Gliquidone (CAS 33342-05-1) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Gliquidone (CAS 33342-05-1) Revenue Share by Type (2021-2026)
Table 34. Global Gliquidone (CAS 33342-05-1) Price (Kg) by Type (2021-2026)
Table 35. Global Gliquidone (CAS 33342-05-1) Sales (Kg) by Application (2015-2020)
Table 36. Global Gliquidone (CAS 33342-05-1) Sales Share by Application (2015-2020)
Table 37. Global Gliquidone (CAS 33342-05-1) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Gliquidone (CAS 33342-05-1) Price (Kg) by Application (2015-2020)
Table 39. Global Gliquidone (CAS 33342-05-1) Sales (Kg) by Application (2021-2026)
Table 40. Global Gliquidone (CAS 33342-05-1) Sales Share by Application (2021-2026)
Table 41. Global Gliquidone (CAS 33342-05-1) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Gliquidone (CAS 33342-05-1) Revenue Share by Application (2021-2026)
Table 43. Global Gliquidone (CAS 33342-05-1) Price (Kg) by Application (2021-2026)
Table 44. United States Gliquidone (CAS 33342-05-1) Sales (Kg) by Company (2015-2020)
Table 45. United States Gliquidone (CAS 33342-05-1) Sales Market Share by Company (2015-2020)
Table 46. United States Gliquidone (CAS 33342-05-1) Sales (Kg) by Type (2015-2020)
Table 47. United States Gliquidone (CAS 33342-05-1) Sales Market Share by Type (2015-2020)
Table 48. United States Gliquidone (CAS 33342-05-1) Sales (Kg) by Application (2015-2020)
Table 49. United States Gliquidone (CAS 33342-05-1) Sales Market Share by Application (2015-2020)
Table 50. Europe Gliquidone (CAS 33342-05-1) Sales (Kg) by Company (2015-2020)
Table 51. Europe Gliquidone (CAS 33342-05-1) Sales Market Share by Company (2015-2020)
Table 52. Europe Gliquidone (CAS 33342-05-1) Sales (Kg) by Type (2015-2020)
Table 53. Europe Gliquidone (CAS 33342-05-1) Sales Market Share by Type (2015-2020)
Table 54. Europe Gliquidone (CAS 33342-05-1) Sales (Kg) by Application (2015-2020)
Table 55. Europe Gliquidone (CAS 33342-05-1) Sales Market Share by Type (2015-2020)
Table 56. China Gliquidone (CAS 33342-05-1) Sales (Kg) by Company (2015-2020)
Table 57. China Gliquidone (CAS 33342-05-1) Sales Market Share by Company (2015-2020)
Table 58. China Gliquidone (CAS 33342-05-1) Sales (Kg) by Type (2015-2020)
Table 59. China Gliquidone (CAS 33342-05-1) Sales Market Share by Type (2015-2020)
Table 60. China Gliquidone (CAS 33342-05-1) Sales (Kg) by Application (2015-2020)
Table 61. China Gliquidone (CAS 33342-05-1) Sales Market Share by Application (2015-2020)
Table 62. Japan Gliquidone (CAS 33342-05-1) Sales (Kg) by Company (2015-2020)
Table 63. Japan Gliquidone (CAS 33342-05-1) Sales Market Share by Company (2015-2020)
Table 64. Japan Gliquidone (CAS 33342-05-1) Sales (Kg) by Type (2015-2020)
Table 65. Japan Gliquidone (CAS 33342-05-1) Sales Market Share by Type (2015-2020)
Table 66. Japan Gliquidone (CAS 33342-05-1) Sales (Kg) by Application (2015-2020)
Table 67. Japan Gliquidone (CAS 33342-05-1) Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Gliquidone (CAS 33342-05-1) Sales (Kg) by Company (2015-2020)
Table 69. Southeast Asia Gliquidone (CAS 33342-05-1) Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Gliquidone (CAS 33342-05-1) Sales (Kg) by Type (2015-2020)
Table 71. Southeast Asia Gliquidone (CAS 33342-05-1) Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Gliquidone (CAS 33342-05-1) Sales (Kg) by Type (2015-2020)
Table 73. Southeast Asia Gliquidone (CAS 33342-05-1) Sales Market Share by Application (2015-2020)
Table 74. India Gliquidone (CAS 33342-05-1) Sales (Kg) by Company (2015-2020)
Table 75. India Gliquidone (CAS 33342-05-1) Sales Market Share by Company (2015-2020)
Table 76. India Gliquidone (CAS 33342-05-1) Sales (Kg) by Type (2015-2020)
Table 77. India Gliquidone (CAS 33342-05-1) Sales Market Share by Type (2015-2020)
Table 78. India Gliquidone (CAS 33342-05-1) Sales (Kg) by Application (2015-2020)
Table 79. India Gliquidone (CAS 33342-05-1) Sales Market Share by Application (2015-2020)
Table 80. Vanguard Pharma Corporation Information
Table 81. Vanguard Pharma Description and Business Overview
Table 82. Vanguard Pharma Gliquidone (CAS 33342-05-1) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Vanguard Pharma Gliquidone (CAS 33342-05-1) Product
Table 84. Vanguard Pharma Recent Development
Table 85. Yiling Pharma Corporation Information
Table 86. Yiling Pharma Description and Business Overview
Table 87. Yiling Pharma Gliquidone (CAS 33342-05-1) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Yiling Pharma Gliquidone (CAS 33342-05-1) Product
Table 89. Yiling Pharma Recent Development
Table 90. CR Double-Crane Corporation Information
Table 91. CR Double-Crane Description and Business Overview
Table 92. CR Double-Crane Gliquidone (CAS 33342-05-1) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. CR Double-Crane Gliquidone (CAS 33342-05-1) Product
Table 94. CR Double-Crane Recent Development
Table 95. TIPR Corporation Information
Table 96. TIPR Description and Business Overview
Table 97. TIPR Gliquidone (CAS 33342-05-1) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. TIPR Gliquidone (CAS 33342-05-1) Product
Table 99. TIPR Recent Development
Table 100. Jinheng Pharma Corporation Information
Table 101. Jinheng Pharma Description and Business Overview
Table 102. Jinheng Pharma Gliquidone (CAS 33342-05-1) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Jinheng Pharma Gliquidone (CAS 33342-05-1) Product
Table 104. Jinheng Pharma Recent Development
Table 105. Dexa Medica Corporation Information
Table 106. Dexa Medica Description and Business Overview
Table 107. Dexa Medica Gliquidone (CAS 33342-05-1) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Dexa Medica Gliquidone (CAS 33342-05-1) Product
Table 109. Dexa Medica Recent Development
Table 110. Boehringer Ingelheim Corporation Information
Table 111. Boehringer Ingelheim Description and Business Overview
Table 112. Boehringer Ingelheim Gliquidone (CAS 33342-05-1) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. Boehringer Ingelheim Gliquidone (CAS 33342-05-1) Product
Table 114. Boehringer Ingelheim Recent Development
Table . Menarini Belgium Corporation Information
Table . Menarini Belgium Gliquidone (CAS 33342-05-1) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . Menarini Belgium Description and Business Overview
Table . Menarini Belgium Gliquidone (CAS 33342-05-1) Product
Table . Menarini Belgium Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Gliquidone (CAS 33342-05-1) Distributors List
Table 123. Gliquidone (CAS 33342-05-1) Customers List
Table 124. Market Key Trends
Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 126. Key Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Gliquidone (CAS 33342-05-1) Product Picture
Figure 2. Global Gliquidone (CAS 33342-05-1) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Gliquidone (CAS 33342-05-1) Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies Examples
Figure 7. Retail Pharmacies Examples
Figure 8. Online Pharmacies Examples
Figure 9. Global Gliquidone (CAS 33342-05-1) Sales (Kg) Growth Rate (2015-2026)
Figure 10. Global Gliquidone (CAS 33342-05-1) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Gliquidone (CAS 33342-05-1) Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 12. Global Gliquidone (CAS 33342-05-1) Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Gliquidone (CAS 33342-05-1) Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Gliquidone (CAS 33342-05-1) Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Gliquidone (CAS 33342-05-1) Sales (Kg) Growth Rate (2015-2026)
Figure 16. Europe Gliquidone (CAS 33342-05-1) Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Gliquidone (CAS 33342-05-1) Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Gliquidone (CAS 33342-05-1) Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Gliquidone (CAS 33342-05-1) Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Gliquidone (CAS 33342-05-1) Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Gliquidone (CAS 33342-05-1) Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Gliquidone (CAS 33342-05-1) Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Gliquidone (CAS 33342-05-1) Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Gliquidone (CAS 33342-05-1) Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Gliquidone (CAS 33342-05-1) Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Gliquidone (CAS 33342-05-1) Players Market Share by Revenue in Gliquidone (CAS 33342-05-1) 2015 & 2019
Figure 27. Gliquidone (CAS 33342-05-1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Gliquidone (CAS 33342-05-1) Revenue Share by Type (2015-2020)
Figure 29. Global Gliquidone (CAS 33342-05-1) Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Gliquidone (CAS 33342-05-1) Revenue Share by Application (2015-2020)
Figure 31. Global Gliquidone (CAS 33342-05-1) Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Gliquidone (CAS 33342-05-1) Sales Market Share by Type in 2019
Figure 33. United States Gliquidone (CAS 33342-05-1) Sales Market Share by Type in 2019
Figure 34. Europe Gliquidone (CAS 33342-05-1) Sales Market Share by Company in 2019
Figure 35. Europe Gliquidone (CAS 33342-05-1) Sales Market Share by Type in 2019
Figure 36. Europe Gliquidone (CAS 33342-05-1) Sales Market Share by Application in 2019
Figure 37. China Gliquidone (CAS 33342-05-1) Sales Market Share by Company in 2019
Figure 38. China Gliquidone (CAS 33342-05-1) Sales Market Share by Type in 2019
Figure 39. China Gliquidone (CAS 33342-05-1) Sales Market Share by Application in 2019
Figure 40. Japan Gliquidone (CAS 33342-05-1) Sales Market Share by Company in 2019
Figure 41. Japan Gliquidone (CAS 33342-05-1) Sales Market Share by Type in 2019
Figure 42. Japan Gliquidone (CAS 33342-05-1) Sales Market Share by Application in 2019
Figure 43. Southeast Asia Gliquidone (CAS 33342-05-1) Sales Market Share by Company in 2019
Figure 44. Southeast Asia Gliquidone (CAS 33342-05-1) Sales Market Share by Type in 2019
Figure 45. Southeast Asia Gliquidone (CAS 33342-05-1) Sales Market Share by Application in 2019
Figure 46. India Gliquidone (CAS 33342-05-1) Sales Market Share by Company in 2019
Figure 47. India Gliquidone (CAS 33342-05-1) Sales Market Share by Type in 2019
Figure 48. India Gliquidone (CAS 33342-05-1) Sales Market Share by Application in 2019
Figure 49. Vanguard Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Yiling Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. CR Double-Crane Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. TIPR Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Jinheng Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Dexa Medica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Menarini Belgium Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Key Raw Materials Price Trend
Figure 58. Manufacturing Cost Structure of Gliquidone (CAS 33342-05-1)
Figure 59. Manufacturing Process Analysis of Gliquidone (CAS 33342-05-1)
Figure 60. Gliquidone (CAS 33342-05-1) Industrial Chain Analysis
Figure 61. Channels of Distribution
Figure 62. Distributors Profiles
Figure 63. Porter's Five Forces Analysis
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
徐放性フィルムコーティングの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Sustained Release Film Coating market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sustained Rele…- 徐放性注射剤の世界市場レポート2020 A recently published report by QY Research titled Global Sustained Release Injectables Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provid…
- 徐放性注射剤の世界市場レポート2020 A recently published report by QY Research titled Global Sustained Release Injectables Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provid…
- オフロキサシン錠の世界市場レポート2020 A recently published report by QY Research titled Global Ofloxacin Tablets Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate …
- イルベサルタン錠の世界市場レポート2020 A recently published report by QY Research titled Global Irbesartan Tablets Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate…